B. Hygriv Rao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
B. Hygriv Rao has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Radhika Korabathina
KIMS Fdn & Res Ctr KFRC, Hyderabad, India
4 shared publicationsC Narasimhan
3 shared publicationsSharada Kalavakolanu
3 shared publications- Altaf Ali
Dept. of Genetics, University College of Science, Osmania University, Hyderabad 500007, Andhra Pradesh, India
2 shared publications - Ananthapur Venkateshwari
Department of Cell Biology, Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad, India
2 shared publications Calambur Narasimhan
Department of Electrophysiology, CARE Institute of Medical Sciences, Hyderabad, India
2 shared publications
Latest Publications
- Open Access
- 15 July 2025
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 25 (5) , 323-327
Electrical storm of short coupled ventricular fibrillation- management by neuromodulation and trigger ablation
- 15 July 2025
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 25 (5) , 323-327
Open AccessElectrical storm of short coupled ventricular fibrillation- management by neuromodulation and trigger ablation
- Open Access
- 26 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 6 (5) , 1046-1054
The hope and the hype of artificial intelligence for syncope management
Aims: Syncope remains a diagnostic challenge despite advancements in testing and treatment. Cardiac syncope is an independent predictor of mortality and can be difficult to distinguish from other causes of transient loss of consciousness (TLOC). This paper explores whether artificial intelligence (AI) can improve the evaluation and management of patients with syncope. Methods and results: We conducted a literature review and incorporated the opinions of experts in the fields of syncope and AI. The cause of TLOC is often unclear, hospitalization criteria are ambiguous, diagnostic tests are frequently non-informative, and assessments are costly. Patients are left with unanswered questions and limited guidance. Artificial intelligence (AI) has the potential to optimize syncope evaluation by processing large data sets, detecting imperceptible patterns, and assisting clinicians. However, AI has limitations, including errors, lack of human empathy, and uncertain clinical utility. Liability issues further complicate its integration. We present three viewpoints: (i) AI is crucial for advancing syncope management; (ii) AI can enhance the patient experience; and (iii) AI in syncope care is inevitable. Conclusion: Artificial intelligence may improve syncope diagnosis and management, particularly through machine learning–based test interpretation and wearable device data. However, it has yet to surpass human clinical judgment in complex decision-making. Current challenges include gaps in understanding syncope mechanisms, AI interpretability, generalizability, and clinical integration. Standardized diagnostic approaches, real-world validation, and curated data sets are essential for progress. Artificial intelligence may enhance efficiency and communication but raises concerns regarding confidentiality, bias, inequities, and legal implications.
- 26 June 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 6 (5) , 1046-1054
Open AccessThe hope and the hype of artificial intelligence for syncope management
Aims: Syncope remains a diagnostic challenge despite advancements in testing and treatment. Cardiac syncope is an independent predictor of mortality and can be difficult to distinguish from other causes of transient loss of consciousness (TLOC). This paper explores whether artificial intelligence (AI) can improve the evaluation and management of patients with syncope. Methods and results: We conducted a literature review and incorporated the opinions of experts in the fields of syncope and AI. The cause of TLOC is often unclear, hospitalization criteria are ambiguous, diagnostic tests are frequently non-informative, and assessments are costly. Patients are left with unanswered questions and limited guidance. Artificial intelligence (AI) has the potential to optimize syncope evaluation by processing large data sets, detecting imperceptible patterns, and assisting clinicians. However, AI has limitations, including errors, lack of human empathy, and uncertain clinical utility. Liability issues further complicate its integration. We present three viewpoints: (i) AI is crucial for advancing syncope management; (ii) AI can enhance the patient experience; and (iii) AI in syncope care is inevitable. Conclusion: Artificial intelligence may improve syncope diagnosis and management, particularly through machine learning–based test interpretation and wearable device data. However, it has yet to surpass human clinical judgment in complex decision-making. Current challenges include gaps in understanding syncope mechanisms, AI interpretability, generalizability, and clinical integration. Standardized diagnostic approaches, real-world validation, and curated data sets are essential for progress. Artificial intelligence may enhance efficiency and communication but raises concerns regarding confidentiality, bias, inequities, and legal implications.
- 28 June 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 412, 132302
Management of patients with Reflex Vasovagal syncope with a protocol involving a yoga maneuver Tadasana
- 28 June 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 412, 132302
Management of patients with Reflex Vasovagal syncope with a protocol involving a yoga maneuver Tadasana
- Open Access
- 20 September 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (10)
Stellate ganglion ablation by conventional radiofrequency in patients with electrical storm
Aims: We report a series of patients with Electrical Storm (ES) who underwent bilateral stellate ganglion ablation by using conventional radio frequency (RFA). Methods and results: The procedure was done with fluoroscopic guidance using the COSMAN™ 1A RF Generator and a 22G RF needle (5 cm length and 5 mm active tip). Six patients, four male and two female (mean age 55 ± 7 years and mean LVEF—42 ± 21%) with ES underwent the procedure under fluoroscopic guidance. All patients experienced recurrent ICD shocks or required multiple external defibrillation shocks. There were no procedural complications. All patients survived free of ES at discharge. At a mean follow—up of 22 ± 8months, all were alive free of ES but two patients received appropriate shocks for VT and one patient had VT terminated by ATP. Conclusion: This small series of cases is a proof of concept that neuromodulation by conventional RFA targeting bilateral stellate ganglia appears safe, feasible, and effective in treating selected unstable patients with ES.
- 20 September 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (10)
Open AccessStellate ganglion ablation by conventional radiofrequency in patients with electrical storm
Aims: We report a series of patients with Electrical Storm (ES) who underwent bilateral stellate ganglion ablation by using conventional radio frequency (RFA). Methods and results: The procedure was done with fluoroscopic guidance using the COSMAN™ 1A RF Generator and a 22G RF needle (5 cm length and 5 mm active tip). Six patients, four male and two female (mean age 55 ± 7 years and mean LVEF—42 ± 21%) with ES underwent the procedure under fluoroscopic guidance. All patients experienced recurrent ICD shocks or required multiple external defibrillation shocks. There were no procedural complications. All patients survived free of ES at discharge. At a mean follow—up of 22 ± 8months, all were alive free of ES but two patients received appropriate shocks for VT and one patient had VT terminated by ATP. Conclusion: This small series of cases is a proof of concept that neuromodulation by conventional RFA targeting bilateral stellate ganglia appears safe, feasible, and effective in treating selected unstable patients with ES.
- 5 November 2022
- Published by Elsevier in Indian Heart Journal
- Vol. 74 (5) , 430
Corrigendum to “Metabolic risk factors in first acute coronary syndrome (MERIFACS) study” [Indian Heart J 2022 Jul–Aug;74(4):275–281]
- 5 November 2022
- Published by Elsevier in Indian Heart Journal
- Vol. 74 (5) , 430
Corrigendum to “Metabolic risk factors in first acute coronary syndrome (MERIFACS) study” [Indian Heart J 2022 Jul–Aug;74(4):275–281]
- Open Access
- 3 August 2022
- Published by Elsevier in Indian Heart Journal
- Vol. 74 (4) , 275-281
Metabolic risk factors in first acute coronary syndrome (MERIFACS) Study
- 3 August 2022
- Published by Elsevier in Indian Heart Journal
- Vol. 74 (4) , 275-281
Open AccessMetabolic risk factors in first acute coronary syndrome (MERIFACS) Study
- 31 January 2022
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 8 (2) , 253-254
“Tadasana” Yoga Maneuver for Preventing Vasovagal Syncope Recurrences
- 31 January 2022
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 8 (2) , 253-254
“Tadasana” Yoga Maneuver for Preventing Vasovagal Syncope Recurrences
- Open Access
- 22 September 2021
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 2 (3) , 133-134
Using CMRI to Make the Unpredictable Less Hazy
- 22 September 2021
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 2 (3) , 133-134
Open AccessUsing CMRI to Make the Unpredictable Less Hazy
- Open Access
- 10 June 2021
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 2 (2) , 69-70
Yoga—the New Panacea for Cardiovascular Illness—Is It Underutilized?
- 10 June 2021
- Published by SAGE Publications in Indian Journal of Clinical Cardiology
- Vol. 2 (2) , 69-70
Open AccessYoga—the New Panacea for Cardiovascular Illness—Is It Underutilized?
- Open Access
- 9 March 2021
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 21 (2) , 88
SCD following myocardial infarction- Predicting the unpredictable
- 9 March 2021
- Published by Elsevier in Indian Pacing and Electrophysiology Journal
- Vol. 21 (2) , 88
Open AccessSCD following myocardial infarction- Predicting the unpredictable